Herish Garresori

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial

Knut Jørgen Labori, Svein Olav Bratlie, Bodil Andersson et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 206 citations

Medicine, Oncology, Surgery +9

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer

Morten Lapin, Satu Oltedal, Kjersti Tjensvoll et al. · Journal of Translational Medicine · 2018 · 140 citations · Full text

Medicine, Molecular Biology, Oncology +13

Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer

Morten Lapin, Karin H. Edland, Kjersti Tjensvoll et al. · Clinical Cancer Research · 2023 · 46 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Surgery of the primary tumour in 201 patients with high‐grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine‐non‐neuroendocrine neoplasms

Hans‐Christian Pommergaard, Kirstine Nielsen, Halfdan Sørbye et al. · Journal of Neuroendocrinology · 2021 · 42 citations · Full text

Medicine, Oncology, Surgery +17

Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients – 30 months follow‐up

Trine‐Lise Larsen, Herish Garresori, Jorunn Brekke et al. · Journal of Thrombosis and Haemostasis · 2022 · 42 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17